Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.6 SEK | +2.32% | +3.22% | +14.24% |
May. 14 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For several months, analysts have been revising their EPS estimates roughly upwards.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.24% | 235M | C- | ||
+6.84% | 26.97B | B+ | ||
-40.08% | 2.67B | B- | ||
-19.95% | 2.4B | C+ | ||
+16.30% | 2.28B | B | ||
+7.28% | 2.24B | - | A- | |
-13.56% | 1.82B | - | ||
+16.67% | 1.79B | B | ||
+18.92% | 1.26B | B | ||
-5.27% | 1.21B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BACTI B Stock
- Ratings Bactiguard Holding AB